Regulation of erythropoietin production
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The glycoprotein hormone erythropoietin (EPO) is an essential growth and survival factor for erythroid progenitor cells, and the rate of red blood cell production is normally determined by the serum EPO concentration. EPO production is inversely related to oxygen availability, so that an effective feedback loop is established, which controls erythropoiesis. Since recombinant EPO became available as an effective therapeutic agent, significant progress has also been made in understanding the basis of this feedback control. The main determinant of EPO synthesis is the transcriptional activity of its gene in liver and kidneys, which is related to local oxygen tensions. This control is achieved by hypoxia‐inducible transcription factors (HIF), consisting of a constitutive β‐subunit and one of two alternative oxygen‐regulated HIFα subunits (HIF‐1α and HIF‐2α). In the presence of oxygen (normoxia) the HIFα subunits are hydroxylated, which targets them for proteasomal degradation. Under hypoxia, because of the lack of molecular oxygen, HIF cannot be hydroxylated and is thereby stabilized. Although HIF‐1α was the first transcription factor identified through its ability to bind to an enhancer sequence of the EPO gene, more recent evidence suggests that HIF‐2α is responsible for the regulation of EPO. Although EPO is a prime example for an oxygen‐ regulated gene, the role of the HIF system goes far beyond the regulation of EPO, because it operates widely in almost all cells and controls a broad transcriptional response to hypoxia, including genes involved in cell metabolism, angiogenesis and vascular tone. Further evidence suggests that apart from its effect as an erythropoietic hormone EPO acts as a paracrine, tissue‐protective protein in the brain and possibly also in other organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135
Research works printed but not linked: 66
- Miescher F, 1893, Ueber die Beziehungen zwischen Meereshöhe und Beschaffenheit des Blutes. Korrespbl, Schweiz Arz, 23, 809
- 10.1126/science.2326648 · DOI · Paper page
- 10.1097/01.ASN.0000107561.59698.42 · DOI
- 10.1097/00062752-199805000-00004 · DOI
- Chen C, 2003, Erythropoietin: molecular biology and clinical use, 165
- Caro J, 1979, Erythropoietin levels in uremic nephric and anephric patients, J Lab Clin Med, 93, 449
- Halvorsen S, 1968, Erythropoietin production in nephrectomized and hypophysectomized animals, Am J Physiol, 215, 349, 10.1152/ajplegacy.1968.215.2.349 · doi:10.1152/ajplegacy.1968.215.2.349
- 10.1152/ajpregu.00115.2004 · DOI
- 10.1128/MCB.6.7.2731 · DOI · Paper page
- 10.1152/ajprenal.1992.263.3.F474 · DOI · Paper page
- 10.1172/JCI115652 · DOI · Paper page
- 10.1038/ki.1991.181 · DOI
- 10.1111/j.1600-0609.1986.tb02626.x · doi:10.1111/j.1600-0609.1986.tb02626.x
- 10.1177/41.3.8429197 · DOI · Paper page
- 10.1038/ki.1993.362 · DOI · Paper page
- 10.1182/blood.V77.11.2497.2497 · DOI · Paper page
- 10.1182/blood.V84.6.1823.1823 · DOI · Paper page
- 10.1182/blood.V77.2.271.271 · DOI · Paper page
- 10.1007/BF00374666 · DOI
- 10.1084/jem.172.2.657 · doi:10.1084/jem.172.2.657
- 10.1007/BF00370520 · DOI
- 10.1111/j.1365-2141.1985.tb02846.x · DOI
- 10.1038/ki.1987.241 · DOI
- Eckardt KU, 1992, Renal innervation plays no role in oxygen‐dependent control of erythropoietin mRNA levels, Am J Physiol, 263, F925
- 10.1182/blood.V74.2.645.645 · DOI · Paper page
- 10.1038/ki.1993.115 · DOI
- 10.1007/BF00587756 · DOI · Paper page
- 10.1152/ajprenal.1990.259.6.F910 · DOI · Paper page
- 10.1159/000183585 · doi:10.1159/000183585
- 10.1007/BF00581229 · DOI
- Eckardt KU, 1989, Regulation of erythropoietin production is related to proximal tubular function, Am J Physiol, 256, F942
- 10.1073/pnas.83.18.6920 · DOI
- 10.1038/313806a0 · DOI · Paper page
- 10.1073/pnas.82.22.7580 · DOI · Paper page
- 10.1016/S0021-9258(18)45504-4 · DOI · Paper page
- 10.1128/MCB.12.12.5373 · DOI · Paper page
- 10.1073/pnas.88.23.10553 · DOI · Paper page
- 10.1515/BC.2004.016 · DOI · Paper page
- 10.1182/blood.V92.7.2260 · DOI · Paper page
- 10.1097/01.ASN.0000017223.49823.2A · DOI · Paper page
- 10.1096/fj.02-0445fje · DOI · Paper page
- 10.1096/fj.04-1640fje · DOI · Paper page
- 10.1073/pnas.88.19.8725 · DOI · Paper page
- 10.1038/ki.1997.387 · DOI
- 10.1016/S0022-3476(88)80573-0 · DOI
- 10.1038/ki.1996.518 · doi:10.1038/ki.1996.518
- 10.1182/blood.V79.8.1987.1987 · DOI · Paper page
- 10.1046/j.1523-1755.2002.00140.x · DOI
- 10.2337/diacare.24.3.495 · DOI · Paper page
- 10.1172/JCI114280 · doi:10.1172/jci114280
- Kazal LA, 1975, Erythropoietin production in renal tumors, Ann Clin Lab Sci, 5, 98
- 10.1111/j.1749-6632.1974.tb14452.x · doi:10.1111/j.1749-6632.1974.tb14452.x
- 10.1016/S0022-5347(17)58490-6 · doi:10.1016/s0022-5347(17)58490-6
- Silva JL, 1990, Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia, Blood, 75, 577, 10.1182/blood.V75.3.577.577 · DOI · Paper page
- 10.1056/NEJM199609193351207 · DOI · Paper page
- Wiesener MS, 2001, Constitutive activation of hypoxia‐inducible genes related to overexpression of hypoxia‐inducible factor‐1alpha in clear cell renal carcinomas, Cancer Res, 61, 5215
- 10.1182/blood.V99.10.3562 · DOI · Paper page
- Berridge MV, 1988, Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat, Blood, 72, 970, 10.1182/blood.V72.3.970.bloodjournal723970 · DOI
- 10.1172/JCI112796 · DOI · Paper page
- Erbayraktar S, 2003, Erythropoietin is a multifunctional tissue‐protective cytokine, Curr Hematol Rev, 2, 465
- 10.1177/1073858403259187 · DOI
- 10.1242/jeb.01049 · DOI · Paper page
- 10.1096/fj.02-1191fje · DOI · Paper page
- 10.1172/JCI18200 · DOI · Paper page
- 10.1161/01.CIR.0000078635.89229.8A · DOI · Paper page
- 10.1182/blood-2002-02-0605 · DOI
Cited by
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo
Rankin, E. B., Biju, M. P., Liu, Q., Unger, T. L., Rha, J., Johnson, R. S., Simon, M. C., Keith, B., & Haase, V. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30117 · Cited by 596
Red blood cells in sports: Effects of exercise and training on oxygen supply by red blood cells
Mairbäurl, H. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00332 · Cited by 482
Suppression of hepcidin during anemia requires erythropoietic activity
Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472
Ott, S. J., El Mokhtari, N. E., Musfeldt, M., Hellmig, S., Freitag, S., Rehman, A., Kühbacher, T., Nikolaus, S., Namsolleck, P., Blaut, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.579979 · Cited by 391
Singhal, R., & Shah, Y. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011188 · Cited by 376
Metadata
- Authors
- Eckardt, K. ‐., & Kurtz, A.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2005-10-27
- Volume
- 35
- Issue
- s3
- Pages
- 13-19
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W1991122654
- Cited by
- 152
- References
- 3
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of erythropoietin production. https://app.cochat.ai/papers/10.1111/j.1365-2362.2005.01525.x
- The paper
- Eckardt, K. ‐., & Kurtz, A. (2005). Regulation of erythropoietin production. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2005.01525.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.